Submission of Research for Review
All study-related submissions (including request to amend approved protocols) must be submitted in PRISM. The exceptions to this rule are:
- exception requests should be submitted to IRBMail@nyspi.columbia.edu
- Serious Adverse Event should be submitted to SAEform@nypsi.columbia.edu
- Protocol Violation forms should be submitted to the IRB Research Monitor via IRBMail@nyspi.columbia.edu
All other Correspondence
We welcome your questions, and we ask that your use our email address for all other communication. Please include the NYSPI-IRB protocol number in the subject line of all correspondence.
Please note: IRB main office reads and "triages" IRBmail daily, have ready access to protocol files, and assign each query for response. Please DO NOT email IRB Analysts or the Chair directly on protocol matters as this risks loss or delay in responding to your request. It is also not necessary to cc any of us individually on queries addressed to IRBMail. Urgent patient care related queries will be forwarded immediately to the Chairman from IRBMail.
|Address||1051 Riverside Drive, Box 10, New York, NY 10032|
|Location||Suite 5200, New PI Building|
IRB Staff Members
Corinne Rogers, MS, CIP
Phone: (646) 774-7162
Andria Whited, MSW, CIP
Cynthia Desmond, JD, MS
IRB Research Monitor
Phone: (646) 774-6543
Stephanie Collins-Reed, Ph.D
Phone: (646) 774-7151
Please contact the IT Help Line, 646-774-6506 for technical questions, Mon-Fri between 9:00am-5:00pm.
Clinical Trials contact